BR0008577A - Use of sex hormones to obtain a nasal pharmaceutical composition useful for treating unwanted uterine bleeding - Google Patents

Use of sex hormones to obtain a nasal pharmaceutical composition useful for treating unwanted uterine bleeding

Info

Publication number
BR0008577A
BR0008577A BR0008577-4A BR0008577A BR0008577A BR 0008577 A BR0008577 A BR 0008577A BR 0008577 A BR0008577 A BR 0008577A BR 0008577 A BR0008577 A BR 0008577A
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
uterine bleeding
composition useful
sex hormones
nasal pharmaceutical
Prior art date
Application number
BR0008577-4A
Other languages
Portuguese (pt)
Inventor
Yannis Tsouderos
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of BR0008577A publication Critical patent/BR0008577A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"UTILIZAçãO DE HORMÈNIOS SEXUAIS PARA A OBTENçãO DE UMA COMPOSIçãO FARMACêUTICA NASAL úTIL PARA O TRATAMENTO DOS SANGRAMENTOS UTERINOS INDESEJáVEIS". A invenção refere-se à utilização de um hormónio sexual para a obtenção de uma composição farmacêutica que convém para a administração por via nasal para tratar os fenómenos de sangramentos uterinos indesejáveis na mulher."USE OF SEXUAL HORMONES TO OBTAIN A USEFUL NASAL PHARMACEUTICAL COMPOSITION FOR TREATMENT OF UNDESIRABLE UTERINE BLEEDINGS". The invention relates to the use of a sex hormone to obtain a pharmaceutical composition suitable for nasal administration to treat the phenomena of undesirable uterine bleeding in women.

BR0008577-4A 1999-03-31 2000-03-30 Use of sex hormones to obtain a nasal pharmaceutical composition useful for treating unwanted uterine bleeding BR0008577A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9904022A FR2791572A1 (en) 1999-03-31 1999-03-31 Treating undesirable uterine bleeding, e.g. as side-effect of hormone therapy, by intranasal administration of estradiol
PCT/FR2000/000790 WO2000059447A2 (en) 1999-03-31 2000-03-30 Use of sex hormones to obtain a nasal pharmaceutical composition that is useful in the treatment of undesirable uterine bleeding

Publications (1)

Publication Number Publication Date
BR0008577A true BR0008577A (en) 2002-10-01

Family

ID=9543854

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0008577-4A BR0008577A (en) 1999-03-31 2000-03-30 Use of sex hormones to obtain a nasal pharmaceutical composition useful for treating unwanted uterine bleeding

Country Status (16)

Country Link
EP (1) EP1143978A2 (en)
JP (1) JP2002541076A (en)
KR (1) KR20010102464A (en)
CN (1) CN1346273A (en)
AU (1) AU3662300A (en)
BR (1) BR0008577A (en)
CA (1) CA2361885A1 (en)
EA (1) EA200100801A1 (en)
FR (1) FR2791572A1 (en)
HK (1) HK1044486A1 (en)
HU (1) HUP0200244A3 (en)
NO (1) NO20014022D0 (en)
NZ (1) NZ513672A (en)
PL (1) PL356767A1 (en)
WO (1) WO2000059447A2 (en)
ZA (1) ZA200106689B (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4383993A (en) * 1980-05-30 1983-05-17 University Of Kentucky Research Foundation Nasal dosage forms containing natural female sex hormones
NL8801670A (en) * 1988-07-01 1990-02-01 Walter Adrianus Josephus Johan PHARMACEUTICAL PREPARATION.
US5922699A (en) * 1996-06-07 1999-07-13 Pherin Corporation 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function
PL331357A1 (en) * 1996-07-23 1999-07-05 Pherin Pharmaceuticals Steroids as neurochemical vno stimulators for soothing the symptoms of premenstrual tension and anxiety

Also Published As

Publication number Publication date
AU3662300A (en) 2000-10-23
CA2361885A1 (en) 2000-10-12
HK1044486A1 (en) 2002-10-25
NO20014022L (en) 2001-08-17
HUP0200244A3 (en) 2003-05-28
WO2000059447A3 (en) 2001-04-26
WO2000059447A2 (en) 2000-10-12
JP2002541076A (en) 2002-12-03
NO20014022D0 (en) 2001-08-17
FR2791572A1 (en) 2000-10-06
ZA200106689B (en) 2002-11-14
NZ513672A (en) 2001-09-28
CN1346273A (en) 2002-04-24
EP1143978A2 (en) 2001-10-17
PL356767A1 (en) 2004-07-12
KR20010102464A (en) 2001-11-15
HUP0200244A2 (en) 2002-07-29
EA200100801A1 (en) 2002-04-25

Similar Documents

Publication Publication Date Title
BR0015974A (en) Use of levetiracetam, pharmaceutical composition, use of a pharmaceutical composition and methods to treat a patient administered with an amount of at least one compound and a disease and to selectively potentiate the therapeutic effect of a compound
BR9916694A (en) Composition of facial tissue and method of use for sequestration of skin irritants from nasal secretion
BR0317747A (en) Method of concomitant therapeutic treatment of an individual, pharmaceutical composition, kit, use of a first agent and a second agent, and methods of preventing or treating amyloid-b-related disease, alzheimer's disease and mild cognitive impairment
BR0115109A (en) Therapeutic agents and methods of their use for angiogenesis modulation
BR0011740A (en) Administration of non-oral androgenic steroids to women
BR9911071A (en) Preparations for the application of anti-inflammatory agents, especially antiseptics and / or agents that promote healing of wounds in the upper respiratory tract and / or the ear
BR9812134A (en) Pharmaceutical composition for the treatment of dysmenorrhea and premature birth
BR0113134A (en) Bisphosphonate vaginal application
BR9910066A (en) Fluid pharmaceutical composition that allows the controlled release of at least one active substance, the manufacturing process of a pharmaceutical composition, and the use of a composition
ATE113834T1 (en) COMPOSITION FOR THE TREATMENT OF SCHIZOPHRENIA.
BR9813373A (en) Compound, process for preparing it, pharmaceutical composition, process for preparing it, use of a compound, and, processes for effecting immunosuppression and for treating or reducing the risk of reversibly obstructive airway disease in a patient
BR9915621A (en) Coating useful as a distributor of an active ingredient in dressings and bandages
BR0112659A (en) Process for treating vaginal dryness or sexual dysfunction in women during or after menopause and using the compound (diaminohydroxy) toremifene or a pharmaceutically acceptable salt, ester or metabolite thereof
EA200301022A1 (en) HORMONAL REPLACEMENT THERAPY
BR0114665A (en) Use of antiprogestins for prophylaxis and treatment of hormone dependent diseases
BR0316057A (en) Methods of treating, controlling or preventing specific cancer and a disease associated with unwanted angiogenesis and of reducing or preventing an adverse effect associated with the administration of a second active ingredient and with radiation therapy, hormone therapy, biological therapy or immunotherapy in a patient suffering from a specific cancer, pharmaceutical composition and kit
BR0008076A (en) 16-hydroxyestratrienes as selective effect estrogens
BR9712274A (en) Hormonal composition consisting of an estrogen compound and a progestational compound
AR036970A1 (en) ANDROGENIC PHARMACEUTICAL COMPOSITION AND METHOD FOR THE TREATMENT OF DEPRESSION
BR0207866A (en) Use of flumazenil in the preparation of a drug for the treatment of cocaine addiction
BR0008577A (en) Use of sex hormones to obtain a nasal pharmaceutical composition useful for treating unwanted uterine bleeding
MX9307479A (en) USE OF CERTAIN DERIVATIVES OF METHANOBISPHOSPHONIC ACID IN FRACTURE HEALING.
BR0306778A (en) Carboxamidine derivatives and their use in the treatment of vascular diseases
HUP0101005A2 (en) Medicament for preventing and/or treating a mammary carcinoma, containing a steroidal aromatase inhibitor
BR9911103A (en) Antiestrogens, process for their preparation and pharmaceutical use

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Free format text: LES LABORATOIRES SERVIER (FR)

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1925 DE 27/11/2007.